Limits...
Left Atrial Appendage: Physiology, Pathology, and Role as a Therapeutic Target.

Regazzoli D, Ancona F, Trevisi N, Guarracini F, Radinovic A, Oppizzi M, Agricola E, Marzi A, Sora NC, Della Bella P, Mazzone P - Biomed Res Int (2015)

Bottom Line: However, OAC is underutilized due to poor patient compliance and contraindications, especially major bleedings.The Virchow triad synthesizes the pathogenesis of thrombogenesis in AF: endocardial dysfunction, abnormal blood stasis, and altered hemostasis.This paper reviews the physiological and pathophysiological role of the LAA and catheter-based methods of LAA exclusion.

View Article: PubMed Central - PubMed

Affiliation: Non-Invasive Cardiology, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milano, Italy.

ABSTRACT
Atrial fibrillation (AF) is the most common clinically relevant cardiac arrhythmia. AF poses patients at increased risk of thromboembolism, in particular ischemic stroke. The CHADS2 and CHA2DS2-VASc scores are useful in the assessment of thromboembolic risk in nonvalvular AF and are utilized in decision-making about treatment with oral anticoagulation (OAC). However, OAC is underutilized due to poor patient compliance and contraindications, especially major bleedings. The Virchow triad synthesizes the pathogenesis of thrombogenesis in AF: endocardial dysfunction, abnormal blood stasis, and altered hemostasis. This is especially prominent in the left atrial appendage (LAA), where the low flow reaches its minimum. The LAA is the remnant of the embryonic left atrium, with a complex and variable morphology predisposing to stasis, especially during AF. In patients with nonvalvular AF, 90% of thrombi are located in the LAA. So, left atrial appendage occlusion could be an interesting and effective procedure in thromboembolism prevention in AF. After exclusion of LAA as an embolic source, the remaining risk of thromboembolism does not longer justify the use of oral anticoagulants. Various surgical and catheter-based methods have been developed to exclude the LAA. This paper reviews the physiological and pathophysiological role of the LAA and catheter-based methods of LAA exclusion.

No MeSH data available.


Related in: MedlinePlus

Left atrial appendage occlusion devices: PLAATO device, no longer available (a), Amplatzer Cardiac Plug (b), Watchman (c), and Lariat device (d).
© Copyright Policy - open-access
Related In: Results  -  Collection


getmorefigures.php?uid=PMC4508372&req=5

fig3: Left atrial appendage occlusion devices: PLAATO device, no longer available (a), Amplatzer Cardiac Plug (b), Watchman (c), and Lariat device (d).

Mentions: The vast majority of patients, however, suffers from nonvalvular atrial fibrillation and has no indications for cardiac surgery: this is why in the last decade percutaneous approaches for LAA occlusion were developed. Obstruction of the LAA orifice with an occlusion device [38] or percutaneous suture ligation using an endocardial/epicardial approach [39] is the two alternatives (Figure 3).


Left Atrial Appendage: Physiology, Pathology, and Role as a Therapeutic Target.

Regazzoli D, Ancona F, Trevisi N, Guarracini F, Radinovic A, Oppizzi M, Agricola E, Marzi A, Sora NC, Della Bella P, Mazzone P - Biomed Res Int (2015)

Left atrial appendage occlusion devices: PLAATO device, no longer available (a), Amplatzer Cardiac Plug (b), Watchman (c), and Lariat device (d).
© Copyright Policy - open-access
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC4508372&req=5

fig3: Left atrial appendage occlusion devices: PLAATO device, no longer available (a), Amplatzer Cardiac Plug (b), Watchman (c), and Lariat device (d).
Mentions: The vast majority of patients, however, suffers from nonvalvular atrial fibrillation and has no indications for cardiac surgery: this is why in the last decade percutaneous approaches for LAA occlusion were developed. Obstruction of the LAA orifice with an occlusion device [38] or percutaneous suture ligation using an endocardial/epicardial approach [39] is the two alternatives (Figure 3).

Bottom Line: However, OAC is underutilized due to poor patient compliance and contraindications, especially major bleedings.The Virchow triad synthesizes the pathogenesis of thrombogenesis in AF: endocardial dysfunction, abnormal blood stasis, and altered hemostasis.This paper reviews the physiological and pathophysiological role of the LAA and catheter-based methods of LAA exclusion.

View Article: PubMed Central - PubMed

Affiliation: Non-Invasive Cardiology, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milano, Italy.

ABSTRACT
Atrial fibrillation (AF) is the most common clinically relevant cardiac arrhythmia. AF poses patients at increased risk of thromboembolism, in particular ischemic stroke. The CHADS2 and CHA2DS2-VASc scores are useful in the assessment of thromboembolic risk in nonvalvular AF and are utilized in decision-making about treatment with oral anticoagulation (OAC). However, OAC is underutilized due to poor patient compliance and contraindications, especially major bleedings. The Virchow triad synthesizes the pathogenesis of thrombogenesis in AF: endocardial dysfunction, abnormal blood stasis, and altered hemostasis. This is especially prominent in the left atrial appendage (LAA), where the low flow reaches its minimum. The LAA is the remnant of the embryonic left atrium, with a complex and variable morphology predisposing to stasis, especially during AF. In patients with nonvalvular AF, 90% of thrombi are located in the LAA. So, left atrial appendage occlusion could be an interesting and effective procedure in thromboembolism prevention in AF. After exclusion of LAA as an embolic source, the remaining risk of thromboembolism does not longer justify the use of oral anticoagulants. Various surgical and catheter-based methods have been developed to exclude the LAA. This paper reviews the physiological and pathophysiological role of the LAA and catheter-based methods of LAA exclusion.

No MeSH data available.


Related in: MedlinePlus